Febbo Phillip G.
Chief Scientific & Med Officer
Febbo Phillip G. has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$786K
reported sales (SEC code S)
Companies
1
in the rolling window